Lille

LILLE, France, October 27, 2011 - - Funding Continues Partnership's Fight against Multidrug-Resistant Tuberculosis The Eli Lilly and Company Foundation has committed US $30 million in funding to further support The Lilly MDR-TB Partnership in its fight against multidrug-resistant tuberculosis - a disease that disproportionately affects developing countries and kills more than 150,000 people each year.